Výsledky vyhledávání - "Kush Sachdeva"

Evaluating the effect of a scalable cancer-navigation program on total cost of care

Autor: Scott Campbell Worland, Margot Albin, Brian Dorsey, Kevin Fosnocht, Juan Gomez, Denise Johnstone, Alphan Kirayoglu, Edward Licitra, Ravi Bharat Parikh, Kush Sachdeva, Keith Thompson, Scott Voigt, Shannon Woerner, Robert Jeffrey Green

Publikováno v: Journal of Clinical Oncology. 40:4-4

4 Background: Cancer-patient navigation programs have been shown to reduce total cost of care while improving outcomes. Previous research has focused on navigation programs embedded within a single institution or a single network of practices. We exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5e1ea373fc5eb557b69f3d61e0775928
https://doi.org/10.1200/jco.2022.40.28_suppl.004

Zobrazit plný text záznamu

Preoperative simultaneous fractionated cisplatin and radiation therapy in the treatment of advanced operable stage III and IV squamous cell carcinoma of the head and neck

Autor: Jessica Tyrrell, Michael A. Davis, Kush Sachdeva, Jorge Cassir, Joseph Fanelle, Naim T. Nazha, Gus J. Slotman, Glenda Smith, Rama Sudhindra, James V. Wurzer

Publikováno v: American journal of surgery. 209(3)

In Stage III/IV head and neck squamous cell carcinoma of the head and neck, multidisciplinary treatment is not standardized. This study evaluated preoperative simultaneous radiation therapy and Cisplatin 20 mg/M(2)/4 days during weeks 1, 4, and 7 of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bcfa9da3e4ff9c5cf26bc5d64152262
https://pubmed.ncbi.nlm.nih.gov/25557972

Zobrazit plný text záznamu

Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting

Autor: Tammy K. Stump, Neal J. Meropol, Katrina Armstrong, Brian L. Egleston, J. S. Schwartz, Naa Eghan, Melanie Pirollo, John Robert Beck, Kush Sachdeva, Yu-Ning Wong

Publikováno v: Medical care. 51(9)

When making treatment decisions, cancer patients must make trade-offs among efficacy, toxicity, and cost. However, little is known about what patient characteristics may influence these trade-offs.A total of 400 cancer patients reviewed 2 of 3 styliz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f425d0a430f29b6357a926c1a294da
https://pubmed.ncbi.nlm.nih.gov/23872905

Zobrazit plný text záznamu

Cancer patients’ trade-offs for efficacy, toxicity, and cost

Autor: Tammy K. Stump, Brian L. Egleston, Melanie Pirollo, J. Robert Beck, Neal J. Meropol, Olivia Hamilton, Kush Sachdeva, Naa Eghan, Yu-Ning Wong

Publikováno v: Journal of Clinical Oncology. 30:6021-6021

6021 Background: When making treatment decisions, cancer patients (pts) must make trade-offs between efficacy, toxicity (tox) and cost. However, little is known about how individual characteristics influence these decisions, particularly as many face

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d405adefaafba1dd2508ce6b8cda1cf
https://doi.org/10.1200/jco.2012.30.15_suppl.6021

Zobrazit plný text záznamu